On March 20, the 2025 Wuxi "International Month" and International Cherry Blossom Viewing Week officially kicked off to great ...

With the fate of the BIOSECURE Act currently in limbo, WuXi AppTec is looking on the brighter side for 2025. | With the fate of the BIOSECURE Act currently in limbo, WuXi AppTec is looking on the ...

WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it ...

Wuxi, Jiangsu province, is celebrating its International Month and International Cherry Blossom Week, highlighting the city's ...

AstraZeneca has tapped Korea's Alteogen to develop subcutaneous cancer drugs. Taiho Pharmaceutical is paying $400 million to ...

Wuxi's enchanting cherry blossoms are poised to take center stage as the city, which is located in Jiangsu province, welcomes ...

Gudrun Koppers, the deputy mayor of Bocholt, Germany, was interviewed while attending the opening ceremony of the 2025 Wuxi ...

The FA Cup has always been a stage for surprises, but few predicted the stunning upset that unfolded in the first round this year as Wuxi's Wu Gou triumphed over Shanghai Zetian with a resounding 2-0 ...

Shares in WuXi AppTec rose sharply after the Chinese biotechnology company proposed a special dividend and share buyback following weaker annual results. The company's shares in Hong Kong climbed as ...

Wuxi in East China's Jiangsu province hosted a cooperation and exchange conference as part of the 2025 Wuxi International ...

WuXi XDC Cayman Inc. ('WuXi XDC', or the 'Company', stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug ...

About WuXi XDC WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK) is a leading global CRDMO focused on antibody drug conjugates (ADC) and the broader bioconjugate market.